Puration Confirms Plans To Apply For Canadian Recreational Cannabis Cultivation License
May 14 2018 - 3:38PM
InvestorsHub NewsWire
Puration Confirms Plans To Apply For
Canadian Recreational Cannabis Cultivation
License
Dallas, TX -- May 14, 2018 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) today confirmed plans to apply for a recreational
cannabis cultivation license in Canada. Last week the company
announced the acquisition of Canadian Cannabis Farmers Co-Op to
position Puration for the recreational marijuana market expected to
be legalized nationwide in Canada this summer. The company
followed up the acquisition with an online presentation on the
company’s overall cannabis cultivation business operation and plans
for the future.
“Today, Puration has two separate, but related
business operations,” explained CEO Brian Shibley. “The company
produces and sells the leading CBD infused beverage in the
nutritional sports supplement market under the brand name
EVERx. The company also entered the cannabis cultivation
market with a long-term strategy through the acquisition last year
of First Choice Nursery. First Choice Nursery’s sales have
contributed to Puration’s overall sales in the first quarter of
this year, 2018, by adding to the existing sales of EVERx. We
have comprehensive initiatives underway to grow both the beverage
business and the cultivation business by tapping into Canada’s
legalization of recreational marijuana. We have a new THC
infused beverage for Canada and we have acquired a business that
comes with substantial experience in Canada’s medical marijuana
cultivation market that we believe will be invaluable to us in
pursuing Canada’s recreational marijuana cultivation market. Yes,
Puration plans to apply for a recreational cannabis cultivation
license in Canada.”
For
more information on Puration,
visit http://www.aciconglomerated.com.
Disclaimer/Safe
Harbor:
This
news release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024